Leica Biosystems PD-L1 BOND antibody
Leica Biosystems’ PD-L1 BOND antibody is designed for use on the company’s fully automated BOND IHC and ISH staining platform.
The PD-L1 (programmed death - ligand 1) antibody uses the MKP1A07310 (clone 73-10) expressed by Abcam on behalf of Merck KGaA, which owns all IP rights to this antibody. It joins the ALK (anaplastic lymphoma kinase) antibody as the latest addition to Novocastra’s growing lung menu of primary antibodies.
Leica Biosystems has optimised these two clones into a ready-to-use format for use on the BOND IHC and ISH staining platform. This allows labs to perform ALK and PD-L1 testing on the BOND system with rapid turnaround times, reliable staining and walk-away convenience.
Phone: 1800 625 286
Biosensis MAP2 antibodies
Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...
Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration
The antibodies are specific to CTC surface markers to enable the sensitive and specific...
Microbiologics UV-BioTAG QC microorganisms for quality control testing
UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...
